Banerjee S, Robertson ES. Future Perspectives: Microbiome, Cancer and Therapeutic Promise. In: Robertson ES, editor. Microbiome and Cancer. Cham: Springer International Publishing; 2019 [cited 2022 May 15]. p. 363–89. (Current Cancer Research). Available from: https://doi.org/10.1007/978-3-030-04155-7_17

Integrative HMP (iHMP) Research Network Consortium The integrative human microbiome project. Nature. 2019;569:641–8.

Article  Google Scholar 

Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369–79.

CAS  Article  Google Scholar 

Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T. Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature. Cancer. 2022;128:14–9.

Article  Google Scholar 

Li JKM, Wang LL, Wong CYP, Chiu PKF, Teoh JYC, Kwok HSW, et al. A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy. Prostate Cancer Prostatic Dis. 2021;24:1063–72.

CAS  Article  Google Scholar 

Kure A, Tsukimi T, Ishii C, Aw W, Obana N, Nakato G, et al. Gut environment changes due to androgen deprivation therapy in patients with prostate cancer. Prostate Cancer Prostatic Dis. 2022. Online ahead of print.

Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gregory WT, et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol. 2016;6:78.

Article  Google Scholar 

Abernethy MG, Tsuei A. The bladder microbiome and interstitial cystitis: is there a connection? Curr Opin Obstet Gynecol. 2021;33:469–73.

Article  Google Scholar 

Li K, Chen C, Zeng J, Wen Y, Chen W, Zhao J, et al. Interplay between bladder microbiota and overactive bladder symptom severity: a cross-sectional study. BMC Urol. 2022;22:39.

CAS  Article  Google Scholar 

Lee HY, Wang JW, Juan YS, Li CC, Liu CJ, Cho SY, et al. The impact of urine microbiota in patients with lower urinary tract symptoms. Ann Clin Microbiol Antimicrob. 2021;20:23.

CAS  Article  Google Scholar 

Bajic P, Dornbier RA, Doshi CP, Wolfe AJ, Farooq AV, Bresler L. Implications of the genitourinary microbiota in prostatic disease. Curr Urol Rep. 2019;20:34.

Article  Google Scholar 

Kim MS, Jung SI. The urinary tract microbiome in male genitourinary diseases: focusing on benign prostate hyperplasia and lower urinary tract symptoms. Int Neurourol J. 2021;25:3–11.

Article  Google Scholar 

Porter CM, Shrestha E, Peiffer LB, Sfanos KS. The microbiome in prostate inflammation and prostate cancer. Prostate Cancer Prostatic Dis. 2018;21:345–54.

CAS  Article  Google Scholar 

Javier-DesLoges J, McKay RR, Swafford AD, Sepich-Poore GD, Knight R, Parsons JK. The microbiome and prostate cancer. Prostate Cancer Prostatic Dis. 2022;25:159–64.

Article  Google Scholar 

Karam A, Mjaess G, Albisinni S, El Daccache Y, Farah M, Daou S, et al. Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature. World J Urol. 2022;40:951–64.

Article  Google Scholar 

Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Del Moral JSG, Gómez-Millán J, et al. The urinary tract microbiome in health and disease. Eur Urol Focus. 2018;4:128–38.

Article  Google Scholar 

Cavarretta I, Ferrarese R, Cazzaniga W, Saita D, Lucianò R, Ceresola ER, et al. The microbiome of the prostate tumor microenvironment. Eur Urol. 2017;72:625–31.

CAS  Article  Google Scholar 

Henning JD, Bonachea LA, Bunker CH, Patrick AL, Jenkins FJ. Human herpesvirus 8 infection contributes to a T helper 2 immune response in men from Tobago with prostate cancer. Int J Urol J Jpn Urol Assoc. 2017;24:64–8.

CAS  Google Scholar 

Yang L, Xie S, Feng X, Chen Y, Zheng T, Dai M, et al. Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis. Sci Rep. 2015;5:14667.

CAS  Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Javurek AB, Spollen WG, Ali AMM, Johnson SA, Lubahn DB, Bivens NJ, et al. Discovery of a novel seminal fluid microbiome and influence of estrogen receptor alpha genetic status. Sci Rep. 2016;6:23027.

CAS  Article  Google Scholar 

Feng Y, Ramnarine VR, Bell R, Volik S, Davicioni E, Hayes VM, et al. Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer. BMC Genomics. 2019;20:146.

Article  Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A Rayyan—a web and mobile app for systematic reviews. Syst Rev [Internet]. 2016 [cited 2022 May 25];5. Available from: https://link.springer.com/epdf/10.1186/s13643-016-0384-4

Holland B, Karr M, Delfino K, Dynda D, El-Zawahry A, Braundmeier-Fleming A, et al. The effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the International Prostate Symptom Score: analysis utilising next-generation sequencing. BJU Int. 2020;125:905–10.

CAS  PubMed  Google Scholar 

Bajic P, Van Kuiken ME, Burge BK, Kirshenbaum EJ, Joyce CJ, Wolfe AJ, et al. Male bladder microbiome relates to lower urinary tract symptoms. Eur Urol Focus. 2020;6:376–82.

Article  Google Scholar 

Thomas S, Dunn CD, Campbell LJ, Strand DW, Vezina CM, Bjorling DE, et al. A multi-omic investigation of male lower urinary tract symptoms: Potential role for JC virus. PloS One. 2021;16:e0246266.

CAS  Article  Google Scholar 

Yu H, Meng H, Zhou F, Ni X, Shen S, Das UN. Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia. Arch Med Sci AMS. 2015;11:385–94.

Article  Google Scholar 

Alexeyev O, Bergh J, Marklund I, Thellenberg-Karlsson C, Wiklund F, Grönberg H, et al. Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden). Cancer Causes Control Ccc 2006;17:1127–33.

CAS  Article  Google Scholar 

Shrestha E, White JR, Yu SH, Kulac I, Ertunc O, De Marzo AM, et al. Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol. 2018;199:161–71.

Article  Google Scholar 

Feng Y, Jaratlerdsiri W, Patrick SM, Lyons RJ, Haynes AM, Collins CC, et al. Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men. Prostate. 2019;79:1731–8.

CAS  Article  Google Scholar 

Alanee S, El-Zawahry A, Dynda D, Dabaja A, McVary K, Karr M, et al. A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis. Prostate. 2019;79:81–7.

CAS  Article  Google Scholar 

Alanee S, El-Zawahry A, Dynda D, McVary K, Karr M, Braundmeier-Fleming A. Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analysis. Prostate Cancer Prostatic Dis. 2019;22:446–52.

CAS  Article  Google Scholar 

Shoskes DA, Altemus J, Polackwich AS, Tucky B, Wang H, Eng C. The urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 2016;92:26–32.

Article  Google Scholar 

Wu Y, Jiang H, Tan M, Lu X. Screening for chronic prostatitis pathogens using high-throughput next-generation sequencing. Prostate. 2020;80:577–87.

CAS  Article  Google Scholar 

Kogan M, Naboka Y, Ferzauli A, Ibishev K, Gudima I, Ismailov R. Does the microbiota spectrum of prostate secretion affect the clinical status of patients with chronic bacterial prostatitis? Int J Urol J Jpn Urol Assoc. 2021;28:1254–9.

Google Scholar 

Bučević Popović V, Šitum M, Chow CET, Chan LS, Roje B, Terzić J. The urinary microbiome associated with bladder cancer. Sci Rep. 2018;8:12157.

Article  Google Scholar 

Hurst R, Meader E, Gihawi A, Rallapalli G, Clark J, Kay GL, et al. Microbiomes of urine and the prostate are linked to human prostate cancer risk groups. Eur Urol Oncol. 2022;5:412–9.

Article  Google Scholar 

Perez-Carrasco V, Soriano-Lerma A, Soriano M, Gutiérrez-Fernández J, Garcia-Salcedo JA. Urinary microbiome: yin and yang of the urinary tract. Front Cell Infect Microbiol. 2021;11:617002.

CAS  Article  Google Scholar 

Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012;10:174.

CAS  Article  Google Scholar 

Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 2014;5:e01283–01214.

CAS  Article  Google Scholar 

Boonanantanasarn K, Gill AL, Yap Y, Jayaprakash V, Sullivan MA, Gill SR. Enterococcus faecalis enhances cell proliferation through hydrogen peroxide-mediated epidermal growth factor receptor activation. Infect Immun. 2012;80:3545–58.

CAS  Article  Google Scholar 

Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392–400.

CAS  Article  Google Scholar 

Higuchi R, Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, et al. Sphingomonas and phenylobacterium as major microbiota in thymic epithelial tumors. J Pers Med. 2021;11:1092.

Article  Google Scholar 

Koh GY, Kane A, Wu X, Mason J, Crott J. Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers, and promotes intestinal barrier integrity in azoxymethane-treated mice (OR04-02-19). Curr Dev Nutr. 2019;3 Suppl 1:nzz030.OR04-02-19.

Lozano-Lorca M, Salcedo-Bellido I, Olmedo-Requena R, Castaño-Vinyals G, Amiano P, Shivappa N, et al. Dietary inflammatory index and prostate cancer risk: MCC-Spain study. Prostate Cancer Prostatic Dis. 2022. Online ahead of print.